Karen R. Dunne, M.S.,CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1015 Oconor Ave, La Salle, IL 61301 Phone: 815-223-0303 Fax: 815-223-5815 |
Sarah Lavieri, M.S. CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 206 Marquette St, La Salle, IL 61301 Phone: 815-224-1988 |
Jeanna Richelle Olivero Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Mary Senica Ct, La Salle, IL 61301 Phone: 815-579-7799 |
Veronica Barbara Jenkins, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1165 Saint Vincents Ave, La Salle, IL 61301 Phone: 815-223-4006 |
Speech Suite 815 Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 838 1st St, La Salle, IL 61301 Phone: 815-200-8830 Fax: 815-714-6202 |
Joscelyn Catrine Pohar Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 941 6th St, La Salle, IL 61301 Phone: 815-224-3261 Fax: 815-224-4512 |
Bree N Carlson, MS. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1015 Oconor Ave, La Salle, IL 61301 Phone: 815-223-0303 |
Mrs. Kristin Ann Wackerlin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1015 Oconor Ave, La Salle, IL 61301 Phone: 815-830-0718 |
Susan May Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 297 N 33rd Rd, La Salle, IL 61301 Phone: 815-223-2933 |
News Archive
AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."
Anyone who has tried and failed to meditate knows that our minds are rarely still. But where do they roam? New research led by UC Berkeley has come up with a way to track the flow of our internal thought processes and signal whether our minds are focused, fixated or wandering.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Antibiotic treatment with amoxicillin/clavulanate improves moderate exacerbations in patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) and significantly prolongs the time between exacerbations, according to a new study from researchers in Spain.
› Verified 7 days ago